• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发展草药产品的策略,以减少干重的自然变异性对压片性能和片剂特性的影响。

Development strategies for herbal products reducing the influence of natural variance in dry mass on tableting properties and tablet characteristics.

机构信息

Laboratoire de Conception et d´Application de Molécules Bioactives (UMR-7199), Faculté de Pharmacie, UdS-CNRS, 67400 Illkirch-Graffenstaden, France.

出版信息

Pharmaceutics. 2012 Oct 8;4(4):501-16. doi: 10.3390/pharmaceutics4040501.

DOI:10.3390/pharmaceutics4040501
PMID:24300367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3834931/
Abstract

One "Quality by Design" approach is the focus on the variability of the properties of the active substance. This is crucially important for active substances that are obtained from natural resources such as herbal plant material and extracts. In this paper, we present various strategies for the development of herbal products especially taking into account the natural batch-to-batch variability (mainly of the dry mass) of tablets that contain a fixed amount of tincture. The following steps in the development have been evaluated for the outcome of the physico-chemical properties of the resulting tablets and intermediates: concentration of the tincture extracted from Echinacea fresh plant, loading of the concentrate onto an inert carrier, the respective wet granulation and drying step, including milling, and the adjuvant excipients for the tablet compression step. The responses that were investigated are the mean particle size of the dried and milled granulates, compaction properties and disintegration time of the tablets. Increased particle size showed a significant increase of the disintegration time and a decrease of the compaction properties. In addition, our results showed that the particle size has a great dependency on the ratio of liquid to carrier during the wet granulation process. Thus, the variability of the respective parameters tested was influenced by the performed strategies, which is how the tincture correlated to its dry mass and the relation of the amount of carrier used. In order to optimize these parameters, a strategy considering the above-mentioned points has to be chosen.

摘要

一种“质量源于设计”的方法是关注活性物质性质的可变性。对于从天然资源(如草药植物材料和提取物)中获得的活性物质,这一点至关重要。在本文中,我们提出了各种草药产品的开发策略,特别是考虑到含有固定剂量酊剂的片剂的天然批次间变异性(主要是干重)。已经评估了以下开发步骤对最终片剂和中间体的物理化学性质的结果:从新鲜西洋蓍草植物中提取的酊剂的浓度、将浓缩物加载到惰性载体上、相应的湿法制粒和干燥步骤,包括粉碎,以及片剂压缩步骤中的赋形剂。研究的响应是干燥和粉碎颗粒的平均粒径、片剂的压缩特性和崩解时间。粒径的增加表明崩解时间显著增加,压缩特性降低。此外,我们的结果表明,粒径在湿法制粒过程中对液体与载体的比例有很大的依赖性。因此,所测试的各参数的可变性受到所采用策略的影响,这就是酊剂与其干重的关系以及所用载体量的关系。为了优化这些参数,必须选择一种考虑到上述要点的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/c0bad79505dc/pharmaceutics-04-00501-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/85c9da8a3713/pharmaceutics-04-00501-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/339659d2bad4/pharmaceutics-04-00501-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/838a325eb7dd/pharmaceutics-04-00501-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/c0bad79505dc/pharmaceutics-04-00501-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/85c9da8a3713/pharmaceutics-04-00501-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/339659d2bad4/pharmaceutics-04-00501-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/838a325eb7dd/pharmaceutics-04-00501-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/124c/3834931/c0bad79505dc/pharmaceutics-04-00501-g008.jpg

相似文献

1
Development strategies for herbal products reducing the influence of natural variance in dry mass on tableting properties and tablet characteristics.发展草药产品的策略,以减少干重的自然变异性对压片性能和片剂特性的影响。
Pharmaceutics. 2012 Oct 8;4(4):501-16. doi: 10.3390/pharmaceutics4040501.
2
Impact of functionalized particle structure on roll compaction/dry granulation and tableting of calcium carbonate.颗粒结构功能化对碳酸钙干法制粒/压片和片剂的影响。
Int J Pharm. 2018 Jun 10;544(1):235-241. doi: 10.1016/j.ijpharm.2018.04.044. Epub 2018 Apr 22.
3
[Tableting technology of a dry extract from Solidago virgaurea L. with the use of silicified microcrystalline cellulose (Prosolv) and other selected auxiliary substances].[使用硅化微晶纤维素(Prosolv)及其他选定辅料对兴安一枝黄花干浸膏进行压片的技术]
Polim Med. 2009;39(4):51-60.
4
Effect of roll-compaction and milling conditions on granules and tablet properties.滚压和研磨条件对颗粒及片剂性质的影响。
Eur J Pharm Biopharm. 2016 Sep;106:38-49. doi: 10.1016/j.ejpb.2016.05.020. Epub 2016 May 27.
5
Investigating the effect of processing parameters on pharmaceutical tablet disintegration using a real-time particle imaging approach.使用实时粒子成像方法研究工艺参数对药物片剂崩解的影响。
Eur J Pharm Biopharm. 2016 Sep;106:88-96. doi: 10.1016/j.ejpb.2016.06.005. Epub 2016 Jun 7.
6
Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting.近红外化学成像(NIR-CI)作为辊压和压片生产线的过程监测解决方案。
Eur J Pharm Biopharm. 2015 Jun;93:293-302. doi: 10.1016/j.ejpb.2015.04.008. Epub 2015 Apr 25.
7
Compression physics in the formulation development of tablets.片剂处方研发中的压缩物理学
Crit Rev Ther Drug Carrier Syst. 2006;23(1):1-65. doi: 10.1615/critrevtherdrugcarriersyst.v23.i1.10.
8
Simulation of roller compaction with subsequent tableting and characterization of lactose and microcrystalline cellulose.乳糖和微晶纤维素的辊压模拟及后续压片与表征
Pharm Dev Technol. 2008;13(6):523-32. doi: 10.1080/10837450802288972.
9
Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.一种存在黏附与成膜问题的活性药物成分的片剂制剂:直接压片和干法制粒评估
Drug Dev Ind Pharm. 2015 Feb;41(2):333-41. doi: 10.3109/03639045.2013.859266. Epub 2013 Nov 27.
10
[Technology for tablets with herbal extracts and evaluation of its quality].含草药提取物的片剂技术及其质量评估
Medicina (Kaunas). 2003;39 Suppl 2:122-6.

引用本文的文献

1
Multivariate Statistical Optimization of Tablet Formulations Incorporating High Doses of a Dry Herbal Extract.含高剂量干草药提取物片剂配方的多元统计优化
Pharmaceutics. 2019 Feb 13;11(2):79. doi: 10.3390/pharmaceutics11020079.

本文引用的文献

1
The evaluation of formulations for the preparation of new formula pellets.新配方丸剂制剂的评价。
Pharm Dev Technol. 2011 Oct;16(5):520-8. doi: 10.3109/10837450.2010.502174. Epub 2010 Jul 22.
2
Importance of evaluating the consolidation of granules manufactured by high shear mixer.评估高剪切混合机制备颗粒的固结情况的重要性。
Int J Pharm. 2007 Jun 29;338(1-2):79-86. doi: 10.1016/j.ijpharm.2007.01.030. Epub 2007 Jan 25.
3
The effect of granule size upon disintegration time and capping in compressed tablets.颗粒大小对压制片崩解时间及裂片的影响。
J Am Pharm Assoc Am Pharm Assoc. 1960 Feb;49:67-9. doi: 10.1002/jps.3030490203.
4
Design of Peumus boldus tablets by direct compression using a novel dry plant extract.采用新型干燥植物提取物通过直接压片法设计波尔多树叶片剂。
Int J Pharm. 2002 Feb 21;233(1-2):191-8. doi: 10.1016/s0378-5173(01)00940-1.
5
Scavenging capacity of berry crops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen.浆果作物对超氧自由基、过氧化氢、羟基自由基和单线态氧的清除能力。
J Agric Food Chem. 2000 Nov;48(11):5677-84. doi: 10.1021/jf000766i.
6
Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial.紫锥菊制剂及其他紫锥菊新鲜植物制剂治疗普通感冒。一项随机、安慰剂对照、双盲临床试验。
Phytomedicine. 1999 Mar;6(1):1-6. doi: 10.1016/S0944-7113(99)80027-0.